Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01035697 · ClinicalTrials.gov registry record

Inflammatory Cytokines Associated With Perinatal Brain Injury

A clinical trial of Cerebral Palsy and Infant, Premature, sponsored by NICHD Neonatal Research Network.

Completed
Registry status
1,067
Enrollment target
18
Study locations

NCT01035697: Completed study of Cerebral Palsy and Infant, Premature, sponsored by NICHD Neonatal Research Network.

NCT01035697 is a study of Cerebral Palsy and Infant, Premature that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 1,067 participants, above the 218-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (389% higher). The trial reports 18 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01035697, a study of Cerebral Palsy and Infant, Premature, has completed, sponsored by NICHD Neonatal Research Network.

COMPLETED
Registry status
1,067 participants
Enrollment target
18
Study locations

Study Summary

This observational study assessed whether measurements of certain pro-inflammatory and anti-inflammatory cytokines in the blood (either singly or in combination) at birth and/or up to day of life 21 can predict cerebral palsy at 18-22 months corrected age.

Study Locations (18)

North Carolina

  • Wake Forest University - Charlotte
  • RTI International - Durham
  • Duke University - Durham

California

  • Stanford University - Palo Alto
  • University of California at San Diego - San Diego

Ohio

  • Cincinnati Children's Medical Center - Cincinnati
  • Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland

Texas

  • University of Texas Southwestern Medical Center at Dallas - Dallas
  • University of Texas Health Science Center at Houston - Houston

Alabama

  • University of Alabama - Birmingham

Connecticut

  • Yale University - New Haven

Florida

  • University of Miami - Miami

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 1,067 participants
Start Date 1999-07
Est. Completion 2004-05
NICHD Neonatal Research Network

61 total trials

What the finished NCT01035697 record still lists

NCT01035697 is an observational study that tracks outcomes without assigning an intervention. Its 1,067 participants enrollment target places it among the larger protocols in the corpus, above the 218-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (389% higher).

The record links to 5 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 0 interventions.

NCT01035697 lists 18 locations in 13 states (North Carolina, California, Ohio).

Frequently Asked Questions

What is clinical trial NCT01035697 about?

NCT01035697 is a clinical study titled "Inflammatory Cytokines Associated With Perinatal Brain Injury". This observational study assessed whether measurements of certain pro-inflammatory and anti-inflammatory cytokines in the blood (either singly or in combination) at birth and/or up to day of life 21 can predict cerebral palsy at 18-22 months corrected age.

What is the current status of trial NCT01035697?

This trial is currently completed. The enrollment target is 1,067 participants. The study started on 1999-07. Estimated completion is 2004-05.

What conditions does trial NCT01035697 study?

This clinical trial studies the following conditions: Cerebral Palsy, Infant, Premature, Infant, Newborn, Infant, Small for Gestational Age, Infant, Low Birth Weight.

Who is sponsoring clinical trial NCT01035697?

This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01035697 being conducted?

This trial has 18 study locations across Alabama, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01035697's enrollment target sits among peer trials

1,067 4th of 91 higher than 88 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04165798 · 1,065 participants

    KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

  • NCT06751043 · 1,072 participants · NA

    Preoperative Fasting vs. Not Fasting in Critically Ill Patients

  • NCT06159673 · 1,074 participants · Phase 2

    ACP-204 in Adults With Alzheimer's Disease Psychosis

  • NCT05520762 · 1,060 participants · NA

    Hospital Airway Resuscitation Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01035697, the US trial registry maintained by the National Library of Medicine. NCT01035697 (large enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.